Article
<span style="mso-no-proof: yes;">The Toxicity of RNA Polymerase Inhibitors Opens the Door to New Drug Generation<span style="font-size: 10.0pt; mso-ansi-font-size: 18.0pt; font-family: 'Times New Roman',serif; mso-ascii-font-family: 'Palatino Linotype'; mso-hansi-font-family: 'Palatino Linotype'; font-weight: normal; mso-ansi-font-weight: bold;"> Modulating Longevity
2025-02-19
Abstract excerpt
There are many RNA polymerase inhibitors, such as rifampicin, which acts as an antituberculosis agent, and relatively new antiviral drugs, such as sofosbuvir. These drugs have a safe profile and strong efficacy in treating tuberculosis and hepatitis C infections. Studies have shown that high doses of these compounds promote cell longevity (prolonging life span) in humans. It is hypothesized that these drugs also a...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- dd76be54-96c9-5af5-94a3-a8a8ec4016d2
- DOI
- 10.20944/preprints202502.1509.v1
